US5447533A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Implantable stimulation lead having an advanceable therapeutic drug delivery system
Assignee: Pacesetter Inc
•
Filing: 1993-10-06
•
Granted: 1995-09-05
•
Expires: 2013-10-06
Abstract
Abstract A pacing lead having a stylet introduced anti-inflammatory drug delivery element advanceable from the distal tip electrode. The element is preferably formed as a moldable biocompatible composite material. The element has a biocompatible matrix material which may be combined with drugs and therapeutic agents to deliver the drugs and agents by co-dissolution or diffusion to the point of either passive or active fixation. The drug delivery element may be rigid and serve to center the active fixation element, preferably a helix, for active fixation of the lead in the myocardium.
Inventors
- 👤 David J. Vachon
- 👤 Shahram Moaddeb
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-31 12:36
CPC Classifications
A; A61; A61N; A61N1/00; A61N1/02; A61N1/04; A61N1/05; A61N1/056; A61N1/057; A61N1/0573; A61N1/0575
Claims Analysis
Total Claims: 13
Claim 1
Independent Claim
142 words
An implantable endocardial pacing lead for use with a cardiac pacemaker comprising: an electrical conductor having a proximal end and a distal end; an insulation sheath covering said conductor, said sheath and said conductor defining an internal chamber extending from said proximal end to said distal end; an electrical connector coupled to said proximal end of said conductor; an active fixation electrode coupled to said distal end of said conductor, said active fixation electrode having a helical electrode advanceable outward relative to the distal end of said conductor for effecting penetration into myocardial tissue; and an advanceable element disposed along an axis of the helical electrode, said advanceable element advanceable relative to the helical electrode for contact with the myocardial tissue, said advanceable element comprising a therapeutic formed of a biocompatible matrix material being of sufficient rigidity to penetrate the myocardial tissue.
Claim 2
Dependent Claim
142 words
An implantable endocardial pacing lead for use with a cardiac pacemaker comprising: an electrical conductor having a proximal end and a distal end; an insulation sheath covering said conductor, said sheath and said conductor defining an internal chamber extending from said proximal end to said distal end; an electrical connector coupled to said proximal end of said conductor; an active fixation electrode coupled to said distal end of said conductor, said active fixation electrode having a helical electrode advanceable outward relative to the distal end of said conductor for effecting penetration into myocardial tissue; and an advanceable element disposed along an axis of the helical electrode, said advanceable element advanceable relative to the helical electrode for contact with the myocardial tissue, said advanceable element comprising a therapeutic formed of a biocompatible matrix material being of sufficient rigidity to penetrate the myocardial tissue.
Claim 3
Dependent Claim
34 words
The pacing lead of claim 1, wherein the biocompatible matrix material is selected from the group consisting of polylactic acid, polyglycolic acid, polylactic/glycolic acids, polyorthoesters, polyesters, polyurethanes, polyanhydrides, polyamino acids, and ion exchange resins.
Claim 4
Dependent Claim
140 words
An implantable endocardial pacing lead for use with a cardiac pacemaker comprising: an electrical conductor having a proximal end and a distal end; an insulation sheath covering said conductor, said sheath and said conductor defining an internal chamber extending from said proximal end to said distal end; an electrical-connector coupled to said proximal end of said conductor; an active fixation electrode coupled to said distal end of said conductor, said active fixation electrode having a helical electrode advanceable, along a longitudinal axis thereof, outward relative to the distal end of said conductor for effecting penetration into myocardial tissue the helical electrode enclosing and thereby defining a cylindrical space; and an advanceable element disposed adjacent the helical electrode, said advanceable element advanceable within the cylindrical space relative to the helical electrode along said longitudinal axis for contact with the myocardial tissue.
Claim 5
Dependent Claim
140 words
An implantable endocardial pacing lead for use with a cardiac pacemaker comprising: an electrical conductor having a proximal end and a distal end; an insulation sheath covering said conductor, said sheath and said conductor defining an internal chamber extending from said proximal end to said distal end; an electrical-connector coupled to said proximal end of said conductor; an active fixation electrode coupled to said distal end of said conductor, said active fixation electrode having a helical electrode advanceable, along a longitudinal axis thereof, outward relative to the distal end of said conductor for effecting penetration into myocardial tissue the helical electrode enclosing and thereby defining a cylindrical space; and an advanceable element disposed adjacent the helical electrode, said advanceable element advanceable within the cylindrical space relative to the helical electrode along said longitudinal axis for contact with the myocardial tissue.
Claim 6
Dependent Claim
28 words
The pacing lead of claim 3, wherein the advanceable element comprises: a therapeutic formed of a biocompatible matrix material being of sufficient rigidity to penetrate the myocardial tissue.
Claim 7
Dependent Claim
125 words
An implantable endocardial pacing lead for use with a cardiac pacemaker comprising: an electrical conductor having a proximal end and a distal end; an insulation sheath covering said conductor, said sheath and said conductor defining an internal chamber extending from said proximal end to said distal end; an electrical connector coupled to said proximal end of said conductor; an active fixation electrode coupled to said distal end of said conductor, said active fixation electrode having a helical electrode advanceable outward relative to the distal end of said conductor for effecting penetration into myocardial tissue; and an advanceable element disposed along an axis of the helical electrode, said advanceable element advanceable relative to the helical electrode, said advanceable element comprising means for penetrating the myocardial tissue.
Claim 8
Dependent Claim
125 words
An implantable endocardial pacing lead for use with a cardiac pacemaker comprising: an electrical conductor having a proximal end and a distal end; an insulation sheath covering said conductor, said sheath and said conductor defining an internal chamber extending from said proximal end to said distal end; an electrical connector coupled to said proximal end of said conductor; an active fixation electrode coupled to said distal end of said conductor, said active fixation electrode having a helical electrode advanceable outward relative to the distal end of said conductor for effecting penetration into myocardial tissue; and an advanceable element disposed along an axis of the helical electrode, said advanceable element advanceable relative to the helical electrode, said advanceable element comprising means for penetrating the myocardial tissue.
Claim 9
Dependent Claim
28 words
The pacing lead of claim 5, wherein the advanceable element comprises: a therapeutic formed of a biocompatible matrix material being of sufficient rigidity to penetrate the myocardial tissue.
Claim 10
Dependent Claim
122 words
An implantable endocardial pacing lead for use with a cardiac pacemaker comprising: an electrical conductor having a proximal end and a distal end; an insulation sheath covering said conductor, said sheath and said conductor defining an internal chamber extending from said proximal end to said distal end; an electrical connector coupled to said proximal end of said conductor; an active fixation electrode coupled to said distal end of said conductor, said active fixation electrode having a helical electrode advanceable outward relative to the distal end of said conductor for effecting penetration into myocardial tissue; and a rigid advanceable element disposed along an axis of the helical electrode, said advanceable element advanceable relative to the helical electrode for penetration into the myocardial tissue.
Claim 11
Dependent Claim
122 words
An implantable endocardial pacing lead for use with a cardiac pacemaker comprising: an electrical conductor having a proximal end and a distal end; an insulation sheath covering said conductor, said sheath and said conductor defining an internal chamber extending from said proximal end to said distal end; an electrical connector coupled to said proximal end of said conductor; an active fixation electrode coupled to said distal end of said conductor, said active fixation electrode having a helical electrode advanceable outward relative to the distal end of said conductor for effecting penetration into myocardial tissue; and a rigid advanceable element disposed along an axis of the helical electrode, said advanceable element advanceable relative to the helical electrode for penetration into the myocardial tissue.
Claim 12
Dependent Claim
19 words
The pacing lead of claim 7, wherein the advanceable element comprises: a therapeutic formed of a biocompatible matrix material.
Claim 13
Dependent Claim
37 words
The pacing lead of claims 4, 6 or 8, wherein the biocompatible matrix material is selected from the group consisting of polylactic acid, polyglycolic acid, polylactic/glycolic acids, polyorthoesters, polyesters, polyurethanes, polyanhydrides, polyamino acids, and ion exchange resins.
References Cited (Backward Citations)
US3757789A
Cited
US4281669A
Cited
US4106512A
Cited
US4146036A
Cited
US4217913A
Cited
US4258724A
Cited
US4282885A
Cited
US4209019A
Cited
US4711251A
Cited
US4711251B1
Cited
US4506680A
Cited
US4954298A
Cited
US4606118A
Cited
US4577642A
Cited
US4649938A
Cited
US4955881A
Cited
US4844099A
Cited
US4827940A
Cited
US4819661A
Cited
US4819662A
Cited
US5103837A
Cited
US4953564A
Cited
US4972848A
Cited
US5002067A
Cited
US5003992A
Cited
US5020545A
Cited
US5261417A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1998-09-04 | 1999-03-06 | 1999-09-05 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2002-09-04 | 2003-03-06 | 2003-09-05 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2006-09-04 | 2007-03-06 | 2007-09-05 | $7700.00 | Window Closed / Lapsed |